Clinical and parasitological response to oral chloroquine and primaquine in uncomplicated human Plasmodium knowlesi infections

Malaria Journal

Volumn 9, Issue 1, 2010, Pages

  Daneshvar, Cyrus ^a   Davis, Timothy M E ^b   Cox Singh, Janet ^a   Rafa'Ee, Mohammad Z ^c   Zakaria, Siti K ^a   Divis, Paul C S ^a   Singh, Balbir ^a  

^a UNIVERSITI MALAYSIA SARAWAK   (Malaysia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c Kapit Hospital   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; PRIMAQUINE; ANTIMALARIAL AGENT;

ADULT; ARTICLE; BORNEO; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FEVER; FOLLOW UP; GAMETOCYTE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALAYSIA; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PLASMODIUM KNOWLESI; PLASMODIUM KNOWLESI MALARIA; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; SCHIZONT; TREATMENT DURATION; TREATMENT RESPONSE; TROPHOZOITE; CLINICAL TRIAL; DRUG COMBINATION; DRUG EFFECT; ISOLATION AND PURIFICATION; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PARASITEMIA; PARASITOLOGY; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; ANTIMALARIALS; BORNEO; CHLOROQUINE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALARIA; MALE; MIDDLE AGED; PARASITEMIA; PLASMODIUM KNOWLESI; PRIMAQUINE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 77955706372     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-9-238     Document Type: Article

References (39)

1. A large focus of naturally acquired Plasmodium knowlesi infections in human beings. B Singh L Kim Sung A Matusop A Radhakrishnan SS Shamsul J Cox-Singh A Thomas DJ Conway, Lancet 2004 363 1017 1024 10.1016/S0140-6736(04) 15836-4 15051281
2. Plasmodium knowlesi malaria in humans is widely distributed and potentially life threatening. J Cox-Singh TM Davis KS Lee SS Shamsul A Matusop S Ratnam HA Rahman DJ Conway B Singh, Clin Infect Dis 2008 46 165 171 10.1086/524888 18171245
3. Knowlesi malaria: newly emergent and of public health importance? J Cox-Singh B Singh, Trends Parasitol 2008 24 406 410 10.1016/j.pt.2008.06.001 18678527
4. Differential prevalence of Plasmodium infections and cryptic Plasmodium knowlesi malaria in humans in Thailand. C Putaporntip T Hongsrimuang S Seethamchai T Kobasa K Limkittikul L Cui S Jongwutiwes, J Infect Dis 2009 199 1143 1150 10.1086/597414 19284284
5. Human Infections with Plasmodium knowlesi, the Philippines. J Luchavez F Espino P Curameng R Espina D Bell P Chiodini D Nolder C Sutherland KS Lee B Singh, Emerg Infect Dis 2008 14 811 813 10.3201/eid1405.071407 18439369
6. Naturally acquired Plasmodium knowlesi malaria in human, Thailand. S Jongwutiwes C Putaporntip T Iwasaki T Sata H Kanbara, Emerg Infect Dis 2004 10 2211 2213 15663864
7. Bionomics of Anopheles latens in Kapit, Sarawak, Malaysian Borneo in relation to the transmission of zoonotic simian malaria parasite Plasmodium knowlesi. CH Tan I Vythilingam A Matusop ST Chan B Singh, Malar J 2008 7 52 10.1186/1475-2875-7-52 18377652
8. Natural transmission of Plasmodium knowlesi to humans by Anopheles latens in Sarawak, Malaysia. I Vythilingam CH Tan M Asmad ST Chan KS Lee B Singh, Trans R Soc Trop Med Hyg 2006 100 1087 1088 10.1016/j.trstmh.2006.02.006 16725166
9. Morphological features and differential counts of Plasmodium knowlesi parasites in naturally acquired human infections. KS Lee J Cox-Singh B Singh, Malar J 2009 8 73 10.1186/1475-2875-8-73 19383118
10. Clinical and laboratory features of human Plasmodium knowlesi infection. C Daneshvar TM Davis J Cox-Singh MZ Rafa'ee SK Zakaria PC Divis B Singh, Clin Infect Dis 2009 49 852 860 10.1086/605439 19635025
11. Monitoring Antimalarial Drug Resistance. WHO, 2001 WHO/CDS/CSR/EPH/200217
12. Increased sensitivity of malaria detection by nested polymerase chain reaction using simple sampling and DNA extraction. J Cox-Singh S Mahayet MS Abdullah B Singh, Int J Parasitol 1997 27 1575 1577 10.1016/S0020-7519(97)00147- 1 9467744
13. Therapeutic responses to different antimalarial drugs in vivax malaria. S Pukrittayakamee A Chantra JA Simpson S Vanijanonta R Clemens S Looareesuwan NJ White, Antimicrob Agents Chemother 2000 44 1680 1685 10.1128/AAC.44.6.1680-1685. 2000 10817728
14. Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic. M Mayxay M Khanthavong N Lindegardh S Keola M Barends T Pongvongsa R Yapom A Annerberg S Phompida R Phetsouvanh NJ White PN Newton, Clin Infect Dis 2004 39 1139 1147 10.1086/424512 15486837
15. A multicenter study of azithromycin, alone and in combination with chloroquine, for the treatment of acute uncomplicated Plasmodium falciparum malaria in India. MW Dunne N Singh M Shukla N Valecha PC Bhattacharyya V Dev K Patel MK Mohapatra J Lakhani R Benner C Lele K Patki, J Infect Dis 2005 191 1582 1588 10.1086/429343 15838784
16. Therapeutic responses to antimalarial and antibacterial drugs in vivax malaria. S Pukrittayakamee M Imwong S Looareesuwan NJ White, Acta Trop 2004 89 351 356 10.1016/j.actatropica.2003.10.012 14744561
17. Artemisinin or chloroquine for blood stage Plasmodium vivax malaria in Vietnam. GT Phan PJ de Vries BQ Tran HQ Le NV Nguyen TV Nguyen SH Heisterkamp PA Kager, Trop Med Int Health 2002 7 858 864 10.1046/j.1365-3156.2002.00948.x 12358621
18. Treatment of chloroquine-resistant Plasmodium vivax with chloroquine and primaquine or halofantrine. JK Baird H Basri B Subianto DJ Fryauff PD McElroy B Leksana TL Richie S Masbar FS Wignall SL Hoffman, J Infect Dis 1995 171 1678 1682 7769318
19. Plasmodium falciparum: in vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria. F ter Kuile NJ White P Holloway G Pasvol S Krishna, Exp Parasitol 1993 76 85 95 10.1006/expr.1993.1010 8467901
20. The efficacy of chloroquine, quinacrine, quinine and totaquine in the treatment of Plasmodium malariae infections (quartan malaria). MD Young DE Eyles, Am J Trop Med 1948 s1-28 23 28
21. Failure to detect hypnozoites in hepatic tissue containing exoerythrocytic schizonts of Plasmodium knowlesi. WA Krotoski WE Collins, Am J Trop Med Hyg 1982 31 854 856 7048949
22. Human Plasmodium knowlesi infection detected by rapid diagnostic tests for malaria. JJ van Hellemond M Rutten R Koelewijn AM Zeeman JJ Verweij PJ Wismans CH Kocken PJ van Genderen, Emerg Infect Dis 2009 15 1478 1480 10.3201/eid1509.090358 19788819
23. Naturally acquired human Plasmodium knowlesi infection, Singapore. OT Ng EE Ooi CC Lee PJ Lee LC Ng SW Pei TM Tu JP Loh YS Leo, Emerg Infect Dis 2008 14 814 816 10.3201/eid1405.070863 18439370
24. Swedish traveller with Plasmodium knowlesi malaria after visiting Malaysian Borneo. U Bronner PC Divis A Farnert B Singh, Malar J 2009 8 15 10.1186/1475-2875-8-15 19146706
25. Monkey malaria in a European traveler returning from Malaysia. A Kantele H Marti I Felger D Muller TS Jokiranta, Emerg Infect Dis 2008 14 1434 1436 10.3201/eid1409.080170 18760013
26. Plasmodium knowlesi in Human, Indonesian Borneo. M Figtree R Lee L Bain T Kennedy S Mackertich M Urban Q Cheng BJ Hudson, Emerg Infect Dis 16 672 674 20350383
27. Plasmodium knowlesi: morphology and course of infection in rhesus monkeys treated with clindamycin and its N-demethyl-4'-pentyl analog. KG Powers M Aikawa KM Nugent, Exp Parasitol 1976 40 13 24 10.1016/0014-4894(76)90058-8 820562
28. [Therapeutic efficacy of naphthoquine phosphate combined with artemisinine against Plasmodium knowlesi] (in Chinese). JY Wang DB Ding GF Li JH Zhao, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 2008 26 442 444 19288919
29. Studies on Nuri Strain of P. knowlesi. IX. Susceptibility to sulphonamide substituted dihydrotriazine, sulphadiazine and mepacrine. AP Ray CP Nair, Indian J Malariol 1955 9 197 202 13285915
30. Blood schizontocidal activity of some antibiotics against Plasmodium knowlesi infection in Assamese monkey. GP Dutta PP Singh, Indian J Med Res 1979 70 Suppl 91 94 121297
31. Treatment of trophozoite-induced Plasmodium knowlesi infection in the rhesus monkey with trimethoprim and sulfalene. WE Rothe DP Jacobus WG Walter, Am J Trop Med Hyg 1969 18 491 494 4978595
32. The blood schizontocidal action of erythromycin against Plasmodium knowlesi infections in Macaca mulatta. DC Warhurst BL Robinson W Peters, Ann Trop Med Parasitol 1983 77 231 237 6625724
33. Mefloquine resistance reversal action of ketoconazole - a cytochrome P450 inhibitor, against mefloquine-resistant malaria. R Tripathi A Awasthi GP Dutta, Parasitology 2005 130 475 479 10.1017/S0031182004006481 15991489
34. Acquired resistance to proguanil in Plasmodium knowlesi. J Singh AP Ray PC Basu CP Nair, Trans R Soc Trop Med Hyg 1952 46 639 649 10.1016/0035-9203(52) 90023-0 13005681
35. Studies on Nuri strain of P. knowlesi. V. Acquired resistance to pyrimethamine. J Singh CP Nair AP Ray, Indian J Malariol 1954 8 187 195 14353521
36. Schizontocidal effects of oral artesunate on Plasmodium berghei in mice and P knowlesi in monkeys. YL Shi GF Li JH Zhao JD Yang DB Ding, Zhongguo Yao Li Xue Bao 1999 20 755 758 10678113
37. Blood schizontocidal activity of a new antimalarial drug, arteether (alpha/beta), against Plasmodium knowlesi in rhesus monkeys. R Bajpai GP Dutta RA Vishwakarma, Trans R Soc Trop Med Hyg 1989 83 484 10.1016/0035-9203(89)90257- 5 2617597
38. Evaluation of the sensitivity in vivo and in vitro of Plasmodium falciparum malaria to quinine in an area of full sensitivity to chloroquine. LA Salako A Sowunmi OJ Laoye, Trans R Soc Trop Med Hyg 1988 82 366 368 10.1016/0035-9203(88)90120-4 3068846
39. Chloroquine treatment of severe malaria in children. Pharmacokinetics, toxicity, and new dosage recommendations. NJ White KD Miller FC Churchill C Berry J Brown SB Williams BM Greenwood, N Engl J Med 1988 319 1493 1500 10.1056/NEJM198812083192301 3054558